Back to Search
Start Over
Anti-tumor necrosis factor-alpha therapy provokes latent leishmaniasis in a patient with rheumatoid arthritis.
- Source :
-
Annals of clinical and laboratory science [Ann Clin Lab Sci] 2009 Spring; Vol. 39 (2), pp. 192-5. - Publication Year :
- 2009
-
Abstract
- It has been reported that anti-tumor necrosis factor-alpha therapy increases the risk of opportunistic infections including rare case reports of leishmaniasis. Here we report a case of latent cutaneous leishmaniasis, which was provoked by anti-tumor necrosis factor-alpha therapy in a patient with rheumatoid arthritis.
- Subjects :
- Adult
Animals
Anti-Bacterial Agents therapeutic use
Antiprotozoal Agents therapeutic use
Biopsy
Female
Humans
Leishmania isolation & purification
Leishmaniasis, Cutaneous pathology
Nasal Mucosa parasitology
Nasal Mucosa pathology
Treatment Outcome
Amphotericin B therapeutic use
Antibodies, Monoclonal adverse effects
Antibodies, Monoclonal therapeutic use
Antirheumatic Agents therapeutic use
Arthritis, Rheumatoid complications
Arthritis, Rheumatoid drug therapy
Leishmaniasis, Cutaneous diagnosis
Nose pathology
Tumor Necrosis Factor-alpha immunology
Subjects
Details
- Language :
- English
- ISSN :
- 1550-8080
- Volume :
- 39
- Issue :
- 2
- Database :
- MEDLINE
- Journal :
- Annals of clinical and laboratory science
- Publication Type :
- Academic Journal
- Accession number :
- 19429808